Day: February 23, 2025

NEW YORK, Feb. 23, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Dr. Gregory George MD PhD, Mesoblast’s largest shareholder, to its Board of Directors. Dr. George founded and managed the largest privately owned ambulatory surgical center company in the United States, SurgCenter Development. Dr. George brings to the Board his background as a medical scientist with unique operational experience having built a start-up company in the medical field and turning it into a highly-efficient multi-billion-dollar commercial organization. Mesoblast Founder and Chief Executive Dr. Silviu Itescu said, “Greg’s unique operational skills and insights will provide tremendous value as Mesoblast transitions to become...

Perth, Feb. 24, 2025 (GLOBE NEWSWIRE) — PERSEUS MINING’S HALF YEAR PROFIT UP 22% TO US$201M, NET CASH & BULLION UP US$117M TO US$704M Perth, Western Australia/ February 24, 2025/Mid-tier, gold producer, developer and explorer, Perseus Mining Limited (ASX/TSX:PRU) is pleased to report material improvements across all key financial metrics including revenue, EBITDA, profit after tax, operating cash flow and net cash position in its Interim Financial Report for the six months ending December 31, 2024 (H1 FY25). HIGHLIGHTSRevenue increased to US$581.8 million, up 19% on prior corresponding period EBITDA(1) up 26% to US$352.7 million on prior corresponding period Profit after Tax increased to US$201 million up 22% on prior corresponding period Operating cash flow increased to US$248 million, up 17% on prior corresponding period Total...

• Findings support the development of a novel peptide vaccine targeting the immunosuppressive effects of Transforming Growth Beta (TGF-β) in solid tumors NEW YORK, Feb. 23, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced details of its poster presentation at the American Association for Cancer Research (AACR)-IO conference taking place February 23-26, 2025, in Los Angeles, California. Poster Presentation DetailsTitle: A TGF-β-directed peptide vaccine induces T cell activation & drives anti-tumor activity by modulating the architecture of the tumor microenvironmentPoster number: B117Presenter: Matteo Bocci, PhD, Senior ScientistDate and time: Tuesday, February 25, 2025, 1:45-4:00 PM PSTLocation:...

CALGARY, Alberta, Feb. 22, 2025 (GLOBE NEWSWIRE) — Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera“, “PEI” or the “Corporation“)  Prospera Energy Inc. (TSXV: PEI, OTC: GXRFF) (“Prospera,” “PEI,” or the “Corporation”) is pleased to announce its 2024 year-end reserves, highlighting significant growth in Proven Developed Producing (“PDP”) and Total Proved plus Probable (“2P”) reserves. The reserves and future net revenue of the Corporation were prepared by InSite Petroleum Consultants Ltd. (“InSite”), an independent qualified reserves evaluator, in accordance with the Canadian Oil and Gas Evaluation Handbook (“COGEH”) standards. InSite prepared a report dated February 21, 2025 (the “InSite Report”), in which it has evaluated, as of December 31, 2024, the oil and...